Glenn Goddard Sells $158K of Intellia Therapeutics Inc (NTLA) — SEC Form 4, Jan 05, 2024
Open-Market Net Sale · SEC Form 4
−$158,053
Equity position changed by -11.7%
Equity Position
40.6K sh
45,950 → 40,585
Equity Change
-11.7%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Glenn Goddard CIK 0001581992 |
CFO
|
Glenn Goddard at Intellia Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Intellia Therapeutics Inc
| 2024-03-05 | Award | — | View |
| 2024-01-03 | Exercise | — | View |
| 2023-03-03 | Award | — | View |
| 2023-01-06 | Sell | -$90,309 | View |
| 2023-01-04 | Exercise | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2024-01-03 | S - Sale | 5,365 D | $29.46 | -$158,053 | 40,585 | Direct |
Footnotes (1)
- F1
- Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2024, and does not represent a volitional trade by the Reporting Person. Show more
Related filings at Intellia Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
328
institutional managers reporting a position
Largest by reported value
- Ark Investment Management Llc $286M
- Black Rock, Inc. $261M
- State Street Corporation $156M
5%+ Holders · 13D/G
5 filers
Other insiders at Intellia Therapeutics Inc
-
John M Leonard -$108K
-
Michael P Dube -$23.2K
-
John M Leonard -$287K
-
Edward J Dulac III -$91.2K
GET /v1/forms/4/0000950170-24-002511
API docs
View Original SEC Filing